Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 03 Aug 2022

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

in Thoracic Oncology

Rachel Evans
Kelvin Lee
Paul K. Wallace
Mary Reid
Jason Muhitch
Askia Dozier
Circe Mesa
Patricia L. Luaces
Orestes Santos-Morales
Adrienne Groman

Frontiers in Oncology

doi 10.3389/fonc.2022.958043

6,579 views
10 citations

Original Research

Published on 02 Aug 2022

A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma

in Thoracic Oncology

Yi Dong
Yingge Li
Yi Yao
Qibin Song

Frontiers in Oncology

doi 10.3389/fonc.2022.897323

4,482 views
10 citations

Correction

Published on 02 Aug 2022

Corrigendum: Successful treatment of a patient with multiple-line relapsed extensive-stage small-cell lung cancer receiving penpulimab combined with anlotinib: A case report

in Thoracic Oncology

Zibo Zhang
Yujun Li
Yan Dong
Jia Li
Bin Zhang
Chunxia Zhang
Xiaonan Cui

Frontiers in Oncology

doi 10.3389/fonc.2022.980842

1,888 views

Original Research

Published on 02 Aug 2022

Id2 exerts tumor suppressor properties in lung cancer through its effects on cancer cell invasion and migration

in Thoracic Oncology

Jian-Ting Chen
Yuan-Ling Hsu
Yi-Chiung Hsu
Yi-Hsin Tseng
Ming-Han Liu
Chia-Wei Weng
Ching-Hao Lin
Szu-Hua Pan
Jeremy J.W. Chen
Chi-Chung Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.801300

3,932 views
9 citations

Review

Published on 02 Aug 2022

Immunotherapy in non-small cell lung cancer: Past, present, and future directions

in Thoracic Oncology

Salman R. Punekar
Elaine Shum
Cassandra Mia Grello
Sally C. Lau
Vamsidhar Velcheti

Frontiers in Oncology

doi 10.3389/fonc.2022.877594

19,575 views
71 citations

Case Report

Published on 01 Aug 2022

Identification of a novel RMST-ALK rearrangement in advanced lung adenocarcinoma and durable response to ceritinib: A case report

in Thoracic Oncology

Hui Li
Yixiao Deng
Bin Chen
Yajie Xiao
Jie Yang
Qionghui Liu
Gengpeng Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.913838

2,312 views

Review

Published on 01 Aug 2022

State-of-the-art combination treatment strategies for advanced stage non–small cell lung cancer

in Thoracic Oncology

Yongfang Yao
Rameesha Fareed
Aliya Zafar
Kalsoom Saleem
Tao Huang
Yongtao Duan
Masood Ur Rehman

Frontiers in Oncology

doi 10.3389/fonc.2022.958505

10,327 views
30 citations

Systematic Review

Published on 01 Aug 2022

An updated network meta-analysis of EGFR-TKIs and combination therapy in the first-line treatment of advanced EGFR mutation positive non-small cell lung cancer

in Thoracic Oncology

Yuexiao Qi
Xiaojun Xia
Lihua Shao
Liyun Guo
Yumei Dong
Jinhui Tian
Lijun Xu
Ruijun Niu
Shihong Wei

Frontiers in Oncology

doi 10.3389/fonc.2022.616546

7,159 views
8 citations

Original Research

Published on 01 Aug 2022

The CURB65 score predicted 180-day mortality of non-small cell lung carcinoma patients with immune checkpoint inhibitor-associated pneumonitis: A pilot retrospective analysis

in Thoracic Oncology

Fen Lan
Bo Fan
Lihua Wang
Lixia Xia
Ting Zhang
Wen Li
Yanxiong Mao

Frontiers in Oncology

doi 10.3389/fonc.2022.927858

2,573 views
1 citation

Original Research

Published on 29 Jul 2022

WNT4 overexpression and secretion in thymic epithelial tumors drive an autocrine loop in tumor cells in vitro

in Thoracic Oncology

Xiaonan Zhang
Berthold Schalke
Krisztian Kvell
Katharina Kriegsmann
Mark Kriegsmann
Thomas Graeter
Gerhard Preissler
German Ott
Katrin Kurz
Elena Bulut

Frontiers in Oncology

doi 10.3389/fonc.2022.920871

3,963 views
6 citations

Original Research

Published on 28 Jul 2022

The correlation between multimodal radiomics and pathology about thermal ablation lesion of rabbit lung VX2 tumor

in Thoracic Oncology

Jin Chen
Yuan Yan
QingFeng Lin
Jian Chen
Jie Chen
ZhengYu Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.941752

2,751 views
4 citations

Original Research

Published on 28 Jul 2022

In 18F-positron emission tomography/computed tomography-guided precision radiotherapy for centrally located non-small cell lung cancer, tumor related atelectasis is a prognostic factor of survival

in Thoracic Oncology

Nan Wang
Yun Qiao
Yingqiu Song
Zheng Wang
Xia Li
Chengsen Liu
Ye Wang
Yu Wu
Rong He
Chenyu Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.898233

2,759 views
1 citation

Original Research

Published on 28 Jul 2022

Synchronous Microwave Ablation Combined With Cisplatin Intratumoral Chemotherapy for Large Non-Small Cell Lung Cancer

in Thoracic Oncology

Guanghui Huang
Wenhong Li
Min Meng
Yang Ni
Xiaoying Han
Jiao Wang
Zhigeng Zou
Tiehong Zhang
Jianjian Dai
Zhigang Wei

Frontiers in Oncology

doi 10.3389/fonc.2022.955545

2,856 views
5 citations

Editorial

Published on 26 Jul 2022

Editorial: Challenges and opportunities of TKIs in the treatment of NSCLC patients with uncommon mutations

in Thoracic Oncology

Chunxia Su
Shi-Yong Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.970315

1,651 views

Correction

Published on 26 Jul 2022

Corrigendum: identification and validation of lncRNA-SNHG17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator

in Thoracic Oncology

Xinyan Li
Yixiao Yuan
Mintu Pal
Xiulin Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.972329

1,560 views

Original Research

Published on 25 Jul 2022

Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients

in Thoracic Oncology

Wen Li
Ziran Bi
Junxu Wu
Xu Duan
Lulian Pang
Yanyan Jing
Xiangxiang Yin
Huaidong Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.772102

2,638 views
5 citations

Case Report

Published on 25 Jul 2022

Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18–18 and EGFR amplification: A case report

in Thoracic Oncology

Pascal Wang
Emmanuelle Fabre
Antoine Martin
Kader Chouahnia
Ambre Benabadji
Lise Matton
Boris Duchemann

Frontiers in Oncology

doi 10.3389/fonc.2022.918855

5,177 views
5 citations

Case Report

Published on 22 Jul 2022

Case report: Two novel intergenic region-ALK fusions in non-small-cell lung cancer resistant to alectinib: A report of two cases

in Thoracic Oncology

Shan Liao
Huiying Sun
Jianhua Wu
Hao Lu
Yisheng Fang
Yuanyuan Wang
Wangjun Liao

Frontiers in Oncology

doi 10.3389/fonc.2022.916315

3,169 views
8 citations

Original Research

Published on 22 Jul 2022

Improved Survival With Surgical Treatment of Primary Lung Lesions in Non-Small Cell Lung Cancer With Brain Metastases: A Propensity‐Matched Analysis of Surveillance, Epidemiology, and End Results Database

in Thoracic Oncology

Qing Wang
Jing Li
Xiaohua Liang
Qiong Zhan

Frontiers in Oncology

doi 10.3389/fonc.2022.888999

3,301 views
6 citations

Clinical Trial

Published on 22 Jul 2022

Long-term outcome following microwave ablation of lung metastases from colorectal cancer

in Thoracic Oncology

Yue Han
Xue Yan
Weihua Zhi
Ye Liu
Fei Xu
Dong Yan

Frontiers in Oncology

doi 10.3389/fonc.2022.943715

5,230 views
15 citations

Opinion

Published on 22 Jul 2022

Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology

in Thoracic Oncology

Filippo de Marinis
Ilaria Attili
Cesare Gridelli
Fabiana Cecere
Carlo Curcio
Francesco Facciolo
Lorenzo Spaggiari

Frontiers in Oncology

doi 10.3389/fonc.2022.971042

3,673 views
4 citations

Original Research

Published on 22 Jul 2022

Clinical M2 Macrophage-Related Genes Can Serve as a Reliable Predictor of Lung Adenocarcinoma

in Thoracic Oncology

Chaojie Xu
Lishan Song
Yubin Yang
Yi Liu
Dongchen Pei
Jiabang Liu
Jianhua Guo
Nan Liu
Xiaoyong Li
Yuchen Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.919899

5,612 views
12 citations

Original Research

Published on 20 Jul 2022

Electrical Impedance Analysis for Lung Cancer: A Prospective, Multicenter, Blind Validation Study

in Thoracic Oncology

Dawei Yang
Chuanjia Gu
Ye Gu
Xiaodong Zhang
Di Ge
Yong Zhang
Ningfang Wang
Xiaoxuan Zheng
Hao Wang
Li Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.900110

4,350 views
8 citations

Case Report

Published on 20 Jul 2022

Case Report: Two Patients With EGFR Exon 20 Insertion Mutanted Non-Small Cell Lung Cancer Precision Treatment Using Patient-Derived Xenografts in Zebrafish Embryos

in Thoracic Oncology

Qian Wang
Wenxian Wang
Weiwei Pan
Xiaojing Lv
Lei Zhang
Kaiming Zheng
Fang Tian
Chunwei Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.884798

4,083 views
4 citations

1,967 articles

articles

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma

Corrigendum: Successful treatment of a patient with multiple-line relapsed extensive-stage small-cell lung cancer receiving penpulimab combined with anlotinib: A case report

Id2 exerts tumor suppressor properties in lung cancer through its effects on cancer cell invasion and migration

Immunotherapy in non-small cell lung cancer: Past, present, and future directions

Identification of a novel RMST-ALK rearrangement in advanced lung adenocarcinoma and durable response to ceritinib: A case report

State-of-the-art combination treatment strategies for advanced stage non–small cell lung cancer

An updated network meta-analysis of EGFR-TKIs and combination therapy in the first-line treatment of advanced EGFR mutation positive non-small cell lung cancer

The CURB65 score predicted 180-day mortality of non-small cell lung carcinoma patients with immune checkpoint inhibitor-associated pneumonitis: A pilot retrospective analysis

WNT4 overexpression and secretion in thymic epithelial tumors drive an autocrine loop in tumor cells in vitro

The correlation between multimodal radiomics and pathology about thermal ablation lesion of rabbit lung VX2 tumor

In 18F-positron emission tomography/computed tomography-guided precision radiotherapy for centrally located non-small cell lung cancer, tumor related atelectasis is a prognostic factor of survival

Synchronous Microwave Ablation Combined With Cisplatin Intratumoral Chemotherapy for Large Non-Small Cell Lung Cancer

Editorial: Challenges and opportunities of TKIs in the treatment of NSCLC patients with uncommon mutations

Corrigendum: identification and validation of lncRNA-SNHG17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator

Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients

Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18–18 and EGFR amplification: A case report

Case report: Two novel intergenic region-ALK fusions in non-small-cell lung cancer resistant to alectinib: A report of two cases

Improved Survival With Surgical Treatment of Primary Lung Lesions in Non-Small Cell Lung Cancer With Brain Metastases: A Propensity‐Matched Analysis of Surveillance, Epidemiology, and End Results Database

Long-term outcome following microwave ablation of lung metastases from colorectal cancer

Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology

Clinical M2 Macrophage-Related Genes Can Serve as a Reliable Predictor of Lung Adenocarcinoma

Electrical Impedance Analysis for Lung Cancer: A Prospective, Multicenter, Blind Validation Study

Case Report: Two Patients With EGFR Exon 20 Insertion Mutanted Non-Small Cell Lung Cancer Precision Treatment Using Patient-Derived Xenografts in Zebrafish Embryos